Clinician fact sheet : Virologic and immunologic characteristics of severe mpox in persons with advanced HIV (VIRISMAP)

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Clinician fact sheet : Virologic and immunologic characteristics of severe mpox in persons with advanced HIV (VIRISMAP)

[PDF-239.90 KB]

English

Details Supporting Files You May Also Like

Details:

Corporate Authors:

National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology.
Description:

Updated April 20, 2023

People with advanced HIV who contract mpox are at risk of severe illness and death. The extent to which the pathology of mpox in patients with advanced HIV is driven by mpox viral effects versus a dysregulated immune response – and potentially immune reconstitution inflammatory syndrome (IRIS) – is unclear. CDC is collaborating with the National Institutes of Health (NIH) to study the extent of mpox viral spread and immunologic markers in people with advanced HIV.

Findings from this study will enhance knowledge of mpox pathogenesis in severely immunocompromised people, which can inform treatment and prevention of severe illness and deaths associated with mpox in people with advanced HIV. The study will include people living in the United States who are at least 18 years old and who have HIV with CD4 count < 200 cells/mL and are hospitalized with probable or confirmed mpox.
Subjects:

[+]

HIV Infections/complications Mpox (monkeypox)/complications
Document Type:

Webpage
Collection(s):

Stephen B. Thacker CDC Library collection
Main Document Checksum:

[+]

urn:sha256:d538698a551b3afe9f0e6c433dd4855fa11495317779c4c7fc6d7e8b40d7ddac
Download URL:

https://stacks.cdc.gov/view/cdc/127337/cdc_127337_DS1.pdf
File Type:

virismap.html

htm

More +